4ed1b591-figure-01 (4ed1b591 Figure 01)
Orphenadrine Citrate
Product Images NDC 66336-554
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 66336-554). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ndc 66336-0554-xx (Ndc 66336 0554 Xx Novel)
The text describes a bulk source data of Orphenadrine Citrate ER 100mg with the MFR Novel Laboratories, Inc. located in Somerset, NJ. Each extended-release tablet contains Orphenadrine Citrate 100mg and is white to off-white and round. It is meant to be taken orally every few hours or as needed, but may cause drowsiness, dizziness or blurred vision and should not be combined with alcohol. The medicine comes in a tight/light resistant container and should be kept away from children at a temperature between 68°- 77° F. The product ID and pedigree number is listed along with the RX number. The lot number, sample exp, and rev date are also displayed. The has some errors and it is unclear what the text in the bottom right corner of the page is referring to, as it seems to be unrelated to the rest of the text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
